End-of-day quote
Shenzhen S.E.
03:30:00 30/04/2024 am IST
|
5-day change
|
1st Jan Change
|
4.42
CNY
|
-9.43%
|
|
-1.56%
|
-26.46%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
58,014
|
44,079
|
30,540
|
23,849
|
23,382
|
17,196
|
-
|
Enterprise Value (EV)
1 |
60,430
|
45,933
|
30,540
|
23,849
|
23,382
|
17,196
|
17,196
|
P/E ratio
|
-64.7
x
|
80.9
x
|
393
x
|
-43.8
x
|
46.2
x
|
20.8
x
|
15.9
x
|
Yield
|
0.36%
|
-
|
-
|
-
|
-
|
0.68%
|
0.9%
|
Capitalization / Revenue
|
6.81
x
|
5.64
x
|
3.34
x
|
-
|
2.15
x
|
1.45
x
|
1.27
x
|
EV / Revenue
|
6.81
x
|
5.64
x
|
3.34
x
|
-
|
2.15
x
|
1.45
x
|
1.27
x
|
EV / EBITDA
|
223
x
|
28.9
x
|
28.8
x
|
-
|
15.5
x
|
7.19
x
|
7.69
x
|
EV / FCF
|
-
|
6,21,76,523
x
|
1,86,21,590
x
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
0%
|
0%
|
-
|
-
|
-
|
-
|
Price to Book
|
7.98
x
|
5.56
x
|
3.82
x
|
-
|
3.06
x
|
2.05
x
|
1.79
x
|
Nbr of stocks (in thousands)
|
38,96,148
|
38,90,481
|
38,90,481
|
38,90,481
|
38,90,481
|
38,90,481
|
-
|
Reference price
2 |
14.89
|
11.33
|
7.850
|
6.130
|
6.010
|
4.420
|
4.420
|
Announcement Date
|
14/04/20
|
12/04/21
|
15/04/22
|
24/04/23
|
24/04/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
8,525
|
7,815
|
9,156
|
-
|
10,894
|
11,869
|
13,490
|
EBITDA
1 |
260.4
|
1,526
|
1,061
|
-
|
1,507
|
2,390
|
2,235
|
EBIT
1 |
-448.8
|
828.6
|
391.2
|
-
|
883.7
|
1,125
|
1,467
|
Operating Margin
|
-5.26%
|
10.6%
|
4.27%
|
-
|
8.11%
|
9.48%
|
10.88%
|
Earnings before Tax (EBT)
1 |
-485.7
|
783.9
|
366.1
|
-
|
848.1
|
1,100
|
1,440
|
Net income
1 |
-866.5
|
554
|
64.14
|
-533.1
|
505.6
|
840.1
|
1,085
|
Net margin
|
-10.16%
|
7.09%
|
0.7%
|
-
|
4.64%
|
7.08%
|
8.05%
|
EPS
2 |
-0.2300
|
0.1400
|
0.0200
|
-0.1400
|
0.1300
|
0.2125
|
0.2775
|
Free Cash Flow
|
-
|
708.9
|
1,640
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
9.07%
|
17.91%
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
46.46%
|
154.55%
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
127.98%
|
2,557.14%
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.0529
|
-
|
-
|
-
|
-
|
0.0300
|
0.0400
|
Announcement Date
|
14/04/20
|
12/04/21
|
15/04/22
|
24/04/23
|
24/04/24
|
-
|
-
|
Fiscal Period: December |
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
---|
Net sales
1 |
-
|
2,310
|
2,812
|
3,676
|
EBITDA
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
Net income
|
-167.2
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
EPS
|
-0.0400
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
27/04/23
|
29/08/23
|
30/10/23
|
24/04/24
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
2,416
|
1,854
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
9.279
x
|
1.215
x
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
709
|
1,640
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-13.8%
|
7.23%
|
0.8%
|
-
|
6.64%
|
10.4%
|
11.4%
|
ROA (Net income/ Total Assets)
|
-4.91%
|
2.97%
|
0.34%
|
-
|
-
|
3.93%
|
4.68%
|
Assets
1 |
17,636
|
18,626
|
18,606
|
-
|
-
|
21,404
|
23,216
|
Book Value Per Share
2 |
1.870
|
2.040
|
2.050
|
-
|
1.970
|
2.160
|
2.480
|
Cash Flow per Share
2 |
0.3200
|
0.2500
|
0.5300
|
-
|
0.5200
|
0.6500
|
0.5200
|
Capex
1 |
429
|
264
|
420
|
-
|
388
|
741
|
790
|
Capex / Sales
|
5.03%
|
3.38%
|
4.59%
|
-
|
3.56%
|
6.25%
|
5.86%
|
Announcement Date
|
14/04/20
|
12/04/21
|
15/04/22
|
24/04/23
|
24/04/24
|
-
|
-
|
Last Close Price
4.42
CNY Average target price
7.763
CNY Spread / Average Target +75.64% Consensus |
1st Jan change
|
Capi.
|
---|
| -26.46% | 2.38B | | +14.10% | 81.84B | | -30.15% | 70.69B | | +9.37% | 29.03B | | -11.90% | 16.97B | | -0.36% | 16.83B | | -1.12% | 15.28B | | +5.90% | 12.41B | | +35.78% | 12.26B | | -4.20% | 11.86B |
Other Healthcare Facilities & Services
|